ScholarIQanswers from OpenAlex

Targeting KRAS for diagnosis, prognosis, and treatment of pancreatic cancer: Hopes and realities

PaperCitations, authors & open-access status

Targeting KRAS for diagnosis, prognosis, and treatment of pancreatic cancer: Hopes and realities is a paper indexed in ScholarIQ from OpenAlex.

How many citations does Targeting KRAS for diagnosis, prognosis, and treatment of pancreatic cancer: Hopes and realities have?

ScholarIQcitation count

Targeting KRAS for diagnosis, prognosis, and treatment of pancreatic cancer: Hopes and realities has 165 citations in the OpenAlex counts ScholarIQ stores.

When was Targeting KRAS for diagnosis, prognosis, and treatment of pancreatic cancer: Hopes and realities published?

ScholarIQyear

Targeting KRAS for diagnosis, prognosis, and treatment of pancreatic cancer: Hopes and realities has 2015 year in the ScholarIQ index.

What is the open-access status of Targeting KRAS for diagnosis, prognosis, and treatment of pancreatic cancer: Hopes and realities?

ScholarIQoa status

Targeting KRAS for diagnosis, prognosis, and treatment of pancreatic cancer: Hopes and realities has closed oa status in the ScholarIQ index.

What is the DOI of Targeting KRAS for diagnosis, prognosis, and treatment of pancreatic cancer: Hopes and realities?

ScholarIQdoi

The DOI for Targeting KRAS for diagnosis, prognosis, and treatment of pancreatic cancer: Hopes and realities is on the source record.

What is the PMID of Targeting KRAS for diagnosis, prognosis, and treatment of pancreatic cancer: Hopes and realities?

ScholarIQpmid

The PMID for Targeting KRAS for diagnosis, prognosis, and treatment of pancreatic cancer: Hopes and realities is on the source record.

What is the OpenAlex record for Targeting KRAS for diagnosis, prognosis, and treatment of pancreatic cancer: Hopes and realities?

ScholarIQopenalex

The OpenAlex for Targeting KRAS for diagnosis, prognosis, and treatment of pancreatic cancer: Hopes and realities is on the source record.

Related on ScholarIQ

470M+ articles · 14-day free trial